Clinical Trial: A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Phase III, Randomized, Double-Blind, Placebo Controlled Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia

Brief Summary: To evaluate the efficacy and safety of IV ferumoxytol compared with placebo for the treatment of iron deficiency anemia (IDA).

Detailed Summary:
Sponsor: AMAG Pharmaceuticals, Inc.

Current Primary Outcome: Hemoglobin changes

Original Primary Outcome: Same as current

Current Secondary Outcome: Patient reported outcomes

Original Secondary Outcome: Same as current

Information By: AMAG Pharmaceuticals, Inc.

Dates:
Date Received: April 29, 2010
Date Started: June 2010
Date Completion:
Last Updated: May 29, 2013
Last Verified: May 2013